Penis, Testis, Urethra, and Other Genitourinary Malignancies

  • Joshua Griffin
  • Moben MirzaEmail author


There are other urologic malignancies that can be seen in the geriatric population. Of those discussed in this chapter, penile cancers are likely the most common that will be encountered in this age group, and early diagnosis and treatment are essential in order to optimize outcomes. Testicular neoplasms, also discussed herein, are not as common but do occur and are usually associated with a good prognosis, although secondary malignancies at this site require different treatment algorithms compared to germ cell tumors. Urethral cancers of both the male and female are exceedingly rare and associated with a poor prognosis unless diagnosed at an early stage. Evaluation and management for these cancers is not different in other age groups; however, comorbid diseases may complicate treatment and outcomes. Lastly, within this group long-term complications of radiation therapy are increasingly seen affecting other organ systems as well as health-related quality of life.


Germ Cell Tumor Testicular Cancer Malignant Mesothelioma Inguinal Lymph Node Serum Tumor Marker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    National Cancer Institute. Testicular Cancer. Available at:
  2. 2.
    National Cancer Institute. SEER Database SEER Stat Fact Sheets: Testes Available at:
  3. 3.
    Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol. 2004;22:2–14.PubMedCrossRefGoogle Scholar
  4. 4.
    Akre O, Pettersson A, Richiardi L. Risk of contralateral testicular cancer among men with unilaterally undescended testis: a meta analysis. Intl J Cancer. 2009;124(3):687–9.CrossRefGoogle Scholar
  5. 5.
    Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. 2007;356:1835–41.PubMedCrossRefGoogle Scholar
  6. 6.
    Wanderas EH, Fossa SD, Tretli S. Risk of second germ cell cancer after treatment of a primary germ cell tumor in 2201 Norwegian male patients. Eur J Can. 1997;33:244–52.CrossRefGoogle Scholar
  7. 7.
    Greene MH, Kratz CP, Mai PL. Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocr Relat Cancer. 2010;17(2):109–21.CrossRefGoogle Scholar
  8. 8.
    Testis (2010) In: Edge SE, Byrd DR, Compton CC, et al., (eds). AJCC cancer staging manual. 7th ed. Springer, New York, NY pp 469–473Google Scholar
  9. 9.
    Fernandez EB, Moul JW, Foley JP, Colon E, McLeod DG. Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors. Urology. 1994;44:548–52.PubMedCrossRefGoogle Scholar
  10. 10.
    Stephenson AJ, Gilligan TD. Neoplasms of the testis. In: Kavoussi LR, Novick AC, Partin AW, Peters CA, Wein A, editors. Campbell-Walsh urology. 10th ed. Philadelphia: Saunders; 2011. p. 848. Ch 31.Google Scholar
  11. 11.
    Salem M, Gilligan T. Serum tumor markers and their utilization in the management of germ-cell tumors in adult males. Exper Rev Anticancer Ther. 2011;11:1–4.CrossRefGoogle Scholar
  12. 12.
    Yoon G, Stein J, Skinner D. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update. Urol Oncol. 2005;23(3):168–77.PubMedCrossRefGoogle Scholar
  13. 13.
    Berney DM, Warren AY, Verma M, et al. Malignant germ cell tumors in the elderly: a histopathological review of 50 cases in men aged 60 years or older. Mod Pathol. 2008;21:54–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Chung PW, Bayley AJ, Sweet J, et al. Spermatocytic seminoma: a review. Eur Urol. 2004;45:495–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Capitanio U, Jeldres C, Perrotte P, et al. Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors. Urology. 2009;74:373–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Chekol S, Chen-Chin S. Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis. Arch Pathol Lab Med. 2012;136:113–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Ikegami Y, Kawai N, Tozawa K, Hayashi Y, Kohri K. Malignant mesothelioma of the tunica vaginalis testis related to recent asbestos. Int J Urol. 2008;15:560–1.PubMedCrossRefGoogle Scholar
  18. 18.
    Abe K, Kato N, Miko K, et al. Malignant mesothelioma of testicular tunica vaginalis. Int J Urol. 2002; 9(10):602–3.PubMedCrossRefGoogle Scholar
  19. 19.
    Darby S, Hancock B. Localised non-Hodgkin lymphoma of the testis: The Sheffield Lymphoma Group Experience. Int J Oncol. 2005;26:1093–9.PubMedGoogle Scholar
  20. 20.
    Kemmerling R, Stintzing S, Mühlmann J, Dietze O, Neureiter D. Primary testicular lymphoma: a strictly homogenous hematological disease? Onc Reports. 2010;23:1261–7.Google Scholar
  21. 21.
    Vural F, Cagirgan S, Saydam G, Hekimgil M, Soyer NA, Tombuloglu M. Primary testicular lymphoma. J Natl Med Assoc. 2007;99:1277–82.PubMedCentralPubMedGoogle Scholar
  22. 22.
    Anghel G, Petti N, Remotti D, Ruscio C, Blandino F, Majolino I. Testicular plasmacytoma: report of a case and review of the literature. Am J Hem. 2002;71:98–104.CrossRefGoogle Scholar
  23. 23.
    American Cancer Society: Cancer Facts and Figures 2012. Available at:
  24. 24.
    Hernandez BY, Barnholtz-Sloan J, German RR, et al. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998–2003. Cancer. 2008;113:2883–91.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Bunker CB. Skin conditions of the male genitalia. Medicine. 2010;38(6):294–9.CrossRefGoogle Scholar
  26. 26.
    Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget’s disease. Br J Dermatol. 2000;142:59–65.PubMedCrossRefGoogle Scholar
  27. 27.
    Doraiswamy V, Biboa J, Obafemi A, Goldschmid M. Leukocytosis and hypercalcemia: a rare combination of paraneoplastic features in squamous cell penile cancer. South Med J. 2010;103:474–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Buddington WT, Kickham CJ, Smith WE. An assessment of malignant disease of the penis. J Urol. 1963;89:442–9.PubMedGoogle Scholar
  29. 29.
    Lucky MA, Rogers B, Parr NJ. Referrals into a dedicated British penile cancer centre and sources of possible delay. Sex Transm Infect. 2009;85:527–30.PubMedCrossRefGoogle Scholar
  30. 30.
    Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27:141–50.PubMedCrossRefGoogle Scholar
  31. 31.
    Chaux A, Cubilla A. Diagnosis, epidemiology, and pathology of penile cancer. In: Scardino P, Linehan W, Zelefsky M, Vogelzang N, editors. Comprehensive textbook of genitourinary oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2011. p. 805–8.Google Scholar
  32. 32.
    Miralles-Guri C, Bruni L, Cubilla AL, Castellsague X, Bosch FX, De Sanjose S. Human papilloma virus prevalence and type distribution in penile carcinoma. J Clin Pathol. 2009;62:870–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005;116:606–16.PubMedCrossRefGoogle Scholar
  34. 34.
    Velazquez EF, Barreto JE, Rodriguez I, Piris A, Cubilla AL. Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma. Int J Surg Pathol. 2004;12:139–46.PubMedCrossRefGoogle Scholar
  35. 35.
    Horenblas S, Van Tinteren H, Delemarre JF, Moonen LM, Lustig V, Kröger R. Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastases classification system and role of lymphangiography, computerized tomography scan, and fine needle aspiration cytology. J Urol. 1991;146:1279–83.PubMedGoogle Scholar
  36. 36.
    Solsona E, Algaba F, Horenblas S, Pizzocaro G, Windahi T. EAU guidelines on penile cancer. Eur Urol. 2004;46:1–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Penis (2010) In: Edge SB, Byrd DR, Compton CC, et al (eds) AJCC cancer staging manual. 7th ed. Springer, New York, NY pp 447–455Google Scholar
  38. 38.
    Agrawal A, Pai D, Ananthakrishnan N, Smile SR, Ratnakar C. The histological extent of the local spread of carcinoma of the penis and its therapeutic implications. BJU Int. 2000;85:299–301.PubMedCrossRefGoogle Scholar
  39. 39.
    Horenblas S, van Tinteren H, Delemarre JF, Boon TA, Moonen LM, Lustig V. Squamous cell carcinoma of the penis II: treatment of the primary tumor. J Urol. 1992;147:1533–8.PubMedGoogle Scholar
  40. 40.
    Souillac I, Avances C, Camparo P, et al. Penile cancer in 2010: update from the oncology committee of the French Association of Urology: External Genital Organs Group (CCAFU-OGE). Prog Urol. 2011;21:909–16.PubMedCrossRefGoogle Scholar
  41. 41.
    Schlenker B, Tilki D, Seitz M, et al. Organ-preserving neodymium-yttrium-aluminum-garnet laser therapy for penile carcinoma: a long-term follow-up. BJU Int. 2010;106:786–90.PubMedCrossRefGoogle Scholar
  42. 42.
    Colecchia M, Nicolai N, Secchi P, et al. pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy. Anal Quant Cytol Histol. 2009;31:153–60.PubMedGoogle Scholar
  43. 43.
    Mohs FE, Snow SN, Larson PO. Mohs micrographic surgery for penile tumors. Urol Clin North Am. 1992;19:291–304.PubMedGoogle Scholar
  44. 44.
    Crook J. Radiation therapy for penile cancer. In: Scardino P, Linehan W, Zelefsky M, Vogelzang N, editors. Comprehensive textbook of genitourinary oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2011. p. 823–9. Chapter 48.Google Scholar
  45. 45.
    McDougall WS, Kirchner FK, Edwards RH, Killion LT. Treatment of carcinoma of the penis. The case for primary lymphadenectomy. J Urol. 1986;136:38–41.Google Scholar
  46. 46.
    Lynch D. Urethral cancer. AUA Update Ser. 2006;25:109–16.Google Scholar
  47. 47.
    Swartz M, Porter M, Lin D, Weiss N. Urology incidence of primary urethral carcinoma in the United States. Urology. 2006;68:1164–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Rabbani F. Prognostic factors in male urethral cancer. Cancer. 2011;117:2426–34.PubMedCrossRefGoogle Scholar
  49. 49.
    Wiener J, Walther P. A high association of oncogenic human papilloma viruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types. J Urol. 1994;151:49–53.PubMedGoogle Scholar
  50. 50.
    Urethra (2010) In: Edge SB, Byrd DR, Compton CC, et al (eds.) American Joint Committee on Cancer Staging Manual, 7th, Springer, New York p 507Google Scholar
  51. 51.
    Dimarco DS, Dimarco CS, Zincke H, et al. Surgical treatment for local control of female urethral carcinoma. Urol Oncol. 2004;22:404–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Zhang N, Gong K, Zhang X, et al. Extramammary Paget’s disease of the scrotum – report of 25 cases and literature review. Urol Oncol. 2010;28:28–33.PubMedCrossRefGoogle Scholar
  53. 53.
    Chattopadhyay M, Sterling J. Skin diseases affecting the vulva. Obstetr Gynaecol Reprod Med. 2011;21(6):169–75.CrossRefGoogle Scholar
  54. 54.
    Chan JYW, Li GKH, Chung JHP, Chow VLY. Extramammary Paget’s disease: 20 years of experience in Chinese population. Int J Surg Oncol. 2012; article ID: 416418.Google Scholar
  55. 55.
    Fanning J, Lambert HC, Hale TM. Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. Am J Obstet Gynecol. 1999;180(1 Pt 1):24–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of UrologyUniversity of Kansas Medical CenterKansas CityUSA
  2. 2.Department of UrologyUniversity of Kansas Hospitals and ClinicsKansas CityUSA

Personalised recommendations